Viatris Recalls Telmisartan and Amlodipine Tablets Due to Superpotent Drug Risk
Viatris is recalling 21,620 bottles of Telmisartan and Amlodipine tablets because the Telmisartan content may exceed specifications.
- Product
- TELMISARTAN AND AMLODIPINE — TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)
- Category
- Drug
- Distribution
- Distributed nationwide